dr. willekens presents efficacy findings for reduced-dose venetoclax in aml
Published 1 month ago • 47 plays • Length 4:42Download video MP4
Download video MP3
Similar videos
-
9:42
christophe willekens, md: reduced venetoclax and azacitidine in aml
-
2:00
dr. dinardo on timing and impact of response to venetoclax combinations in aml
-
2:33
upcoming clinical trials for venetoclax chemotherapy combinations for aml
-
6:53
the efficacy and toxicity of reduced venetoclax exposure in patients with treatment-naïve aml
-
1:01:48
know your aml therapy: venetoclax | dr. alice mims #aml
-
6:53
jacqueline garcia: evaluating venetoclax plus azacitidine in patients with high-risk mds
-
0:55
venetoclax for elderly aml patients
-
1:12
cpx-351 with venetoclax in r/r aml: results of a phase ib study
-
1:32
is venetoclax in combination with low-dose cytarabine a safe regimen for the treatment of aml?
-
18:29
aml treatment challenges who, when, and how
-
4:59
venetoclax plus clad/ldac and aza for older aml patients
-
3:10
venetoclax and azacitidine in newly diagnosed aml patients | dan pollyea, md, ms | ash 2022 #aml
-
3:20
venetoclax combinations effective in elderly aml
-
1:41
dr. dinardo on the rationale for the pooled analysis evaluating venetoclax in aml
-
1:22
dr. schiller on venetoclax and glasdegib in aml
-
4:49
promising results for venetoclax combination therapies in elderly aml
-
9:41
what is venetoclax? #aml
-
3:35
safety and efficacy of venetoclax-based regimens for aml